Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
A clinical trial was designed to evaluate the efficacy and safety of cefotaxime, a new semisynthetic, broad-spectrum cephalosporin, in the therapy of community-and hospital-acquired pneumonias. Thirty-nine males (mean age, 65 years) were treated for 41 episodes of pneumonia. Only five patient did no...
Saved in:
| Published in: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology (ASM)
1982
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181881/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6280600/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.2.327 |
| Tags: |
No Tags, Be the first to tag this record!
|